Clinical Trials on Leukemia Relapse in France

Total 1180 results

Assistance Publique - Hôpitaux de Paris

Active, not recruiting

Blinatumomab in High-risk B-cell Precursor Acute Lymphoblastic Leukemia (GRAALL-QUEST)

Acute Lymphoblastic Leukemia, Adult B-Cell

France
Hospices Civils de Lyon

Unknown

AFR10 - Combination Therapy of Imatinib Mesylate (IM) + Alpha-2A Interferon for Chronic Phase CML Patients Resistant or Refractory to IM Used as Single Therapy for at Least One Year

Chronic Myeloid Leukemia

France
French Innovative Leukemia Organisation

Terminated

Treatment With Bendamustine, Ofatumumab and MethylPrednisolone in Relapsed B-CLL (BOMP)

B-cell Chronic Lymphocytic Leukemia (B-CLL)

France
Institut Paoli-Calmettes

Not yet recruiting

Early Prophylactic Donor Lymphocyte Infusion After Allo-HSCT for Patients With AML (ELIT-AML01)

Acute Myeloid Leukemia

France
University Hospital, Lille
Saint-Louis Hospital, Paris, France; Canceropôle Nord Ouest

Recruiting

Minimal Residual Disease Evaluation on Cryopreserved Ovarian Fragments in Younger Patients Treated for Acute Myeloid Leukemia (FERTILAM)

Acute Myeloid Leukemia

France
University Hospital, Brest

Completed

Invasives Aspergillosis in Acute Myeloid Leukemia (IA-AML)

Acute Myeloid Leukemia | Invasive Aspergillosis

France
GlaxoSmithKline

Completed

Observational Study of Nelarabine in Children and Young Adults

Leukaemia, Lymphoblastic, Acute

Russian Federation, Denmark, France, Germany, Israel, Italy, Netherlands, Poland, Spain
Novartis Pharmaceuticals

Completed

Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia

Leukaemia

Belgium, Austria, Czechia, France, Germany, Israel, Russian Federation, Sweden, United Kingdom, Hungary, Ireland, Italy, Slovakia, Bulgaria, Singapore, Ukraine, Poland
Hospices Civils de Lyon
Novartis

Unknown

Nilotinib ± Peg-IFN for First Line Chronic Phase CML Patients (PETALs)

Chronic Myeloid Leukemia

France
Poitiers University Hospital
Novartis

Completed

Safety and Efficacy of Imatinib in Chronic Myelogenous Patients Older Than 70 Years

Chronic Myeloid Leukemia

France
Bristol-Myers Squibb

Completed

A Study of Dasatinib Management Among CP-CML (Chronic Phase, Chronic Myeloid Leukemia) Participants Initiating Dasatinib in a Real Life Setting

Chronic Myeloid Leukemia

France
University Hospital, Bordeaux
Bordeaux PharmacoEpi

Completed

Budget Impact Analysis of Discontinuing Tyrosin Kinase Inhibitors in Patients With Chronic Myeloid Leukemia Achieving a Complete Molecular Response by Using Probabilistic Markov Approach (ECOSTIM)

Hematologic Diseases | Chronic Myeloid Leukemia

France
Poitiers University Hospital
Novartis; Roche Pharma AG; Ministry of Health, France

Completed

STI571 ProspectIve RandomIzed Trial: SPIRIT (SPIRIT)

Chronic Myeloid Leukemia

France
Novartis Pharmaceuticals

Completed

French Study to Highlight the Unmet Treatment Needs of 3L+ CP-CML and With T315I-mutated CML Patients

Chronic Myeloid Leukemia

France
Poitiers University Hospital
Novartis

Completed

Safety and Efficacy of Imatinib in Chronic Myelogenous Patients in Relapse After Stem Cell Transplantation

Chronic Myeloid Leukemia

France
Poitiers University Hospital
Novartis; Ministry of Health, France

Terminated

Safety and Efficacy of Imatinib in Combination With High Dose Chemotherapy for Acute Phase Chronic Myelogenous Patients

Chronic Myeloid Leukemia

France
Assistance Publique Hopitaux De Marseille

Completed

Laparoscopic Sacrocolpexy Versus Lateral Suspension (SUSPENSION)

Pelvic Organ Prolapse

France
University Hospital, Tours
Roche Pharma AG; French Innovative Leukemia Organisation

Completed

Rituximab Maintenance Versus Observation After First-line Immunochemotherapy by FCR in Older Patients With Chronic Lymphocytic Leukemia (LLC2007SA)

Leukemia

France
Hospices Civils de Lyon

Unknown

Dependence Receptors and Leukemia

Acute Lymphoblastic Leukemia | Acute Leukemia

France
French Innovative Leukemia Organisation

Completed

Liposomal Anthracyclin in the Treatment of Elderly ALL

Acute Lymphoblastic Leukemia

France
French Innovative Leukemia Organisation
Roche Pharma AG; Janssen-Cilag Ltd.

Completed

Phase II Trial GA101 Inbrutinib B CLL (ICLL07GAI)

Leukemia, Lymphocytic, Chronic, B-Cell

France
CHU de Reims

Completed

Role of the Microparticles and of Tissue Factor in the Pro-thrombotic Phenotype and the Thromboembolic Complications During the Acute Lymphoblastic Leukemia in Children. (THROMBLEUKEMIA)

Acute Lymphoblastic Leukemia

France
Assistance Publique - Hôpitaux de Paris
Group for Research in Adult Acute Lymphoblastic Leukemia

Completed

Treatment of Acute Lymphoblastic Leukemia (ALL) in Younger Adults

Leukemia, Lymphocytic

France
Assistance Publique - Hôpitaux de Paris

Completed

Alemtuzumab (CAMPATH 1H) Associated to G-CSF in Adult Patients With Refractory Acute Lymphocytic Leukemia (Campath)

Acute Lymphocytic Leukemia

France
University Hospital, Toulouse
Ministry of Health, France

Completed

Feasibility of Risk-Adapted Therapy in Young Adult Acute Lymphoblastic Leukemia: a Multicenter Trial (GRAALL2003)

Acute Lymphoblastic Leukemia

France
Nantes University Hospital

Unknown

Safety and Efficacy of Radio-immunotherapy (RIT) for Patients With Relapse or Refractory Acute Lymphoblastic Leukaemia (ALL) B CD22+ (RIT 90YEpra)

Acute Lymphoblastic Leukemia

France
Hospices Civils de Lyon

Unknown

Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly With Imatinib Mesylate (STI571) and Chemotherapy.

Acute Lymphocytic Leukemia

France
University Hospital, Angers

Completed

Vascular Dysfunction and Antiangiogenic Therapy (DYVA-AAGG)

Solid Tumor | Endothelial Dysfunction | Tumor Angiogenesis | CML (Chronic Myelogenous Leukemia)

France
University Hospital, Clermont-Ferrand
Pierre Fabre Laboratories

Unknown

Eradication of Residual Disease by Preemptive Immunointervention After Allogeneic Hematopoietic Stem Cells Transplantation in Chronic Lymphocytic Leukemia (RICAC)

Chronic Lymphocytic Leukemia | Lymphocytic Lymphoma

France
French Innovative Leukemia Organisation

Completed

Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMP

Leukemia

France
University Hospital, Caen

Not yet recruiting

Acute Lymphoblastic Leukaemia Related to Lenalidomide (LenALL)

Cancer

France
Hospices Civils de Lyon

Unknown

Alternative Splicing and Leukemia Initiating Cells (ASLIC)

Acute Myeloid Leukemia

France
Genmab
AbbVie

Recruiting

Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome (EPCORE™ CLL-1)

Small Lymphocytic Lymphoma | Richter's Syndrome | Relapsed/Refractory Chronic Lymphocytic Leukemia

United States, Belgium, Netherlands, Spain, Italy, Australia, Israel, France, Denmark, Czechia, Germany, United Kingdom
Poitiers University Hospital

Completed

Evaluation of the Position of Promontofixation Prostheses in Perineal Ultrasound (PROMONOTECHO)

Prolapse of the Uterus

France
Institut Paoli-Calmettes

Unknown

Evaluation of 3 Different Doses of IV Busulfan (AAA)

Acute Myeloid Leukemia | Myelodysplastic Syndrome

France
University Hospital, Caen

Not yet recruiting

Impact of Allo-HSCT on Bone Remodeling: Evolution of Bone Mineral Density and Architecture Measured by Bone Densitometry (REMODALLO)

Myeloid Leukemia, Acute

France
University Hospital, Montpellier

Recruiting

Collection of Biological Samples From Patients Treated With CAR-T Cells for Hematological Malignancies (CAR-T BANK)

Lymphoma and Acute Lymphoblastic Leukemia

France
Centre Hospitalier Universitaire Dijon

Unknown

Preclinical Project on the Traitment of Acute Lymphoblastique Leukemia With NVP-BEP800, an Inhibitor of the Heat Shock Protein HSP90 (HSP-HEMATO)

Acute T Lymphoblastic Leukemia (T-ALL) | Acute B Lymphoblastic Leukemia (B-ALL)

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Multicenter Study of Risk-adapted Treatment for T-lineage ALL of Young Adults (18-59 Years Old) (GRAALL-2014/T)

T-cell Adult Acute Lymphoblastic Leukemia

France
Central Hospital, Nancy, France

Active, not recruiting

Evaluation of the Advantage in the Use of Enteral Nutrition in Children Treated for Acute Lymphoblastic Leukemia

Leukemia, Lymphoblastic

France
French Innovative Leukemia Organisation

Completed

Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III

Leukemia, Lymphocytic, Acute

France
Centre Hospitalier Universitaire de Besancon
Centre Hospitalier Universitaire Dijon; Etablissement Français du Sang

Completed

AML Cell Immunotherapy Using Chimeric Antigen Receptor T-cells (CAR-LAM)

Acute Myeloid Leukemia

France
University Hospital, Angers

Recruiting

Outcome of Patients With CBF and/or NPM1-mutated AML in First Molecular Relapse. (MOLAM)

Acute Myeloid Leukemia

France
Novartis Pharmaceuticals

Terminated

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy (PROLONG)

Leukaemia, Lymphocytic, Chronic

Belgium, Netherlands, United States, Argentina, Czechia, Denmark, France, Greece, Israel, Russian Federation, Sweden, Korea, Republic of, Australia, Brazil, Canada, Italy, Spain, Turkey, Hungary, Finland, Poland, Ukraine, Puerto Rico, Indi... and more
Assistance Publique - Hôpitaux de Paris

Completed

Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their Siblings (PACIFIC)

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Acute Leukemia

France
Centre Hospitalier Universitaire de Nīmes

Recruiting

Is There an Association Between Innate CD8+ T Cells and the Evolution of Tyrosine Kinase Inhibitor Resistance Mutations in Phi+ Hematological Malignancies. (TIPHI)

Leukemia | Chronic Leukemia | Myelogenous Leukemia | BCR-ABL Positive Acute Myeloid Leukemia

France
Hospices Civils de Lyon

Completed

Immunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic Leukemia (RIPAL)

LYMPHOMA

France
Hospices Civils de Lyon

Active, not recruiting

Evolution of Symptoms After Anterior Sacrospinofixation by Autologous Tissues (SANTAU)

Pelvic Organ Prolapse

France
University Hospital, Strasbourg, France

Completed

Study of Outpatient Management for Promontofixation by Laparoscopy

Pelvic Organ Prolapse

France
Technische Universität Dresden
German Federal Ministry of Education and Research; Groupe Francophone des Myelodysplasies and other collaborators

Active, not recruiting

Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia (TUD-APOLLO-064)

Acute Promyelocytic Leukemia

France, Germany, Italy, Netherlands, Spain

Clinical Trials on Leukemia Relapse in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations